Cargando…
Delayed Anaphylaxis to Intravenous Colistin in a Critically Ill Cancer Patient: A Case Report
INTRODUCTION: Anaphylaxis is an acute, life-threatening, multi-system syndrome that has been reported with a wide range of medications. Though anaphylaxis usually has a rapid onset, we describe a patient who developed anaphylaxis to intravenous colistin after 28 days of daily administration. CASE PR...
Autores principales: | Awad, Wedad B, Alsheyyab, Farah, Nazer, Lama, Mahmoud, Naser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841843/ https://www.ncbi.nlm.nih.gov/pubmed/36654733 http://dx.doi.org/10.1177/11795476221149393 |
Ejemplares similares
-
A 12-year study evaluating the outcomes and predictors of mortality in critically ill cancer patients admitted with septic shock
por: Awad, Wedad B., et al.
Publicado: (2021) -
Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015) -
Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022) -
Fatal anaphylaxis to intravenous ondansetron: A case report
por: Sapkota, Kalyan, et al.
Publicado: (2021) -
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
por: Markou, Nikolaos, et al.
Publicado: (2003)